Skip to main content
. Author manuscript; available in PMC: 2020 May 28.
Published in final edited form as: EBioMedicine. 2020 May 24;56:102765. doi: 10.1016/j.ebiom.2020.102765

Figure 1. Flow chart schematic for patient eligibility and follow up for included patients in the study depicting progressors and non-progressors.

Figure 1

BO, Barrett’s oesophagus; RFA, radiofrequency ablation; EMR, endoscopic mucosal resection; ND, non-dysplastic; LGD, low-grade dysplasia; HGD, high-grade dysplasia; OAC, oesophageal adenocarcinoma.